Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
Cardiovascular Risk Reduction in Patients with nonalcoholic fatty liver disease: The Potential Role of Ezetimibe.